StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6681
This month
6
This week
3
This year
1704
Yesterday
3
Publishing Date
2023 - 10 - 24
17
2023 - 10 - 23
16
2023 - 09 - 26
17
2023 - 09 - 11
17
2023 - 06 - 05
23
2023 - 05 - 25
23
2023 - 02 - 13
17
2022 - 12 - 08
21
2022 - 06 - 06
20
2022 - 05 - 23
16
2022 - 03 - 01
17
2022 - 01 - 18
19
2022 - 01 - 04
16
2021 - 12 - 16
16
2021 - 12 - 14
17
2021 - 12 - 13
29
2021 - 12 - 09
23
2021 - 12 - 06
25
2021 - 11 - 30
17
2021 - 11 - 16
19
2021 - 11 - 15
18
2021 - 11 - 09
17
2021 - 11 - 08
19
2021 - 11 - 03
21
2021 - 10 - 28
17
2021 - 10 - 27
16
2021 - 10 - 25
19
2021 - 10 - 20
16
2021 - 10 - 18
17
2021 - 10 - 14
19
2021 - 10 - 13
20
2021 - 10 - 07
21
2021 - 09 - 13
27
2021 - 09 - 09
17
2021 - 09 - 08
21
2021 - 07 - 27
18
2021 - 07 - 15
16
2021 - 07 - 07
15
2021 - 07 - 06
16
2021 - 07 - 01
15
2021 - 06 - 29
18
2021 - 06 - 28
24
2021 - 06 - 24
18
2021 - 06 - 23
25
2021 - 06 - 16
16
2021 - 06 - 08
15
2021 - 06 - 07
22
2021 - 05 - 20
16
2021 - 05 - 12
16
2021 - 04 - 29
15
2021 - 04 - 15
15
2021 - 04 - 12
17
2021 - 03 - 18
19
2021 - 03 - 15
16
2021 - 03 - 10
15
2021 - 03 - 09
15
2021 - 02 - 10
15
2021 - 01 - 11
15
2020 - 12 - 10
17
2020 - 12 - 01
15
Sector
Accommodation and food services
1
Administrative and support and waste management and remediation services
5
Arts, entertainment, and recreation
5
Commercial services
105
Communications
77
Consumer durables
50
Consumer non-durables
28
Consumer services
34
Distribution services
42
Electronic technology
153
Energy minerals
21
Finance
249
Finance and insurance
20
Health care and social assistance
13
Health services
82
Health technology
4092
Industrial services
47
Information
25
Manufacturing
516
Mining, quarrying, and oil and gas extraction
14
Miscellaneous
12
N/a
242
Non-energy minerals
29
Process industries
152
Producer manufacturing
453
Professional, scientific, and technical services
194
Real estate and rental and leasing
8
Retail trade
64
Technology services
178
Transportation
42
Transportation and warehousing
21
Utilities
9
Wholesale trade
1
Tags
Acquisition
7848
Agreement
2536
Application
2265
Approval
2283
Business
3448
Cancer
3996
Ceo
2400
Ces
2927
Collaboration
2243
Conference
21628
Corporation
5015
Covid
2710
Deadline
3773
Disease
2534
Distribution
2875
Drug
2606
Earnings
3571
Energy
7181
Europe
2290
Events
4709
Fda
3251
Financial
13094
Financial results
8251
Global
10240
Group
4463
Growth
12111
Health
4716
International
2055
Management
2395
Market
21565
Media
2136
Meeting
3057
N/a
264944
Nasdaq
3478
Offering
6918
Partnership
2588
People
2345
Pharma
2252
Pharmaceuticals
2375
Platform
2160
Positive
2825
Presentation
2958
Program
3553
Report
14179
Research
9876
Results
38985
Sales
2113
Services
2701
Solutions
2392
Spac
2298
Study
2254
System
2447
Technology
6301
Test
2331
Therapeutics
8462
Therapy
2764
Treatment
4943
Trial
6681
Update
4356
Year
4854
Entities
Abb ltd
72
Abbvie inc.
30
Achieve life sciences, inc.
21
Actinium pharmaceuticals, inc.
22
Aldeyra therapeutics, inc.
31
Alterity therapeutics limited
25
Altra industrial motion corp.
23
Alzamend neuro inc
19
Anavex life sciences corp.
19
Arcutis biotherapeutics, inc.
20
Arrival
21
Ascendis pharma a/s
19
Astellas pharma inc
22
Astrazeneca plc
48
Beigene, ltd.
23
Biovie inc.
22
Bioxcel therapeutics, inc.
25
Bristol-myers squibb company
44
Clearside biomedical, inc.
20
Cnh industrial n.v.
69
Csw industrials, inc.
19
Cybin inc
19
Cytokinetics, incorporated
20
Dynavax technologies corporation
22
Eli lilly and company
107
Exelixis, inc.
26
Fortress biotech, inc.
25
Gates industrial corporation plc
25
Gilead sciences, inc.
21
Global industrial co
37
Honeywell international inc.
53
Horizon therapeutics public limited company
34
Hutchison china meditech limited
20
I-mab
21
Icon plc
21
Immix biopharma, inc.
22
Immunic, inc.
21
Immutep limited
22
Incyte corporation
26
Johnson & johnson
93
Johnson controls international plc
22
Medtronic plc
21
Merck & company, inc.
40
Moleculin biotech, inc.
28
Novartis ag
22
Novavax, inc.
20
Novo nordisk a/s
29
Novocure limited
23
Orange
59
Pds biotechnology corporation
22
Pfizer, inc.
41
Plus therapeutics, inc.
28
Regeneron pharmaceuticals, inc.
28
Regenxbio inc.
23
Sanofi
148
Sellas life sciences group, inc.
21
Sorrento therapeutics, inc.
33
Stag industrial, inc.
32
Takeda pharmaceutical company limited
34
Thermo fisher scientific inc
25
Symbols
ABB
72
ABBV
30
ABLZF
31
ACHV
21
AIMC
23
ALDX
31
ALPMF
22
ALPMY
22
ALZN
19
ARQT
20
ARVL
21
ASND
19
ATHE
25
ATNM
22
AZN
48
BGNE
23
BIVI
22
BMY
44
BTAI
25
CLSD
20
CNHI
69
CYTK
20
DVAX
22
EXEL
26
FBIO
25
FNCTF
59
GIC
37
GILD
21
GTES
25
HCM
20
HON
53
HZNP
34
ICLR
21
IMAB
21
IMMP
22
IMMX
22
IMUX
21
INCY
26
JCI
22
JNJ
93
LLY
107
MBRX
28
MDT
21
MRK
40
NVAX
20
NVCR
23
NVO
29
NVS
22
PDSB
22
PFE
41
PSTV
28
REGN
28
RGNX
23
SLS
21
SNY
148
SNYNF
103
SRNE
33
STAG
32
TAK
34
TMO
25
Exchanges
Amex
94
Lse
45
Nasdaq
5429
Nyse
1590
Tsx
31
Crawled Date
2023 - 10 - 24
17
2023 - 10 - 23
16
2023 - 09 - 26
17
2023 - 09 - 11
17
2023 - 06 - 05
22
2023 - 05 - 25
24
2022 - 12 - 08
23
2022 - 06 - 06
21
2022 - 05 - 23
16
2022 - 03 - 01
17
2022 - 01 - 18
18
2022 - 01 - 04
16
2021 - 12 - 16
16
2021 - 12 - 14
16
2021 - 12 - 13
28
2021 - 12 - 09
21
2021 - 12 - 06
25
2021 - 11 - 30
17
2021 - 11 - 16
20
2021 - 11 - 15
17
2021 - 11 - 09
16
2021 - 11 - 08
21
2021 - 11 - 03
20
2021 - 10 - 28
17
2021 - 10 - 27
16
2021 - 10 - 25
18
2021 - 10 - 20
16
2021 - 10 - 14
20
2021 - 10 - 13
19
2021 - 10 - 07
21
2021 - 09 - 30
15
2021 - 09 - 28
16
2021 - 09 - 13
28
2021 - 09 - 09
17
2021 - 09 - 08
21
2021 - 08 - 31
15
2021 - 08 - 05
15
2021 - 07 - 27
17
2021 - 07 - 15
16
2021 - 07 - 07
15
2021 - 07 - 06
17
2021 - 06 - 29
19
2021 - 06 - 28
22
2021 - 06 - 25
15
2021 - 06 - 24
17
2021 - 06 - 23
26
2021 - 06 - 16
16
2021 - 06 - 08
15
2021 - 06 - 07
22
2021 - 05 - 20
16
2021 - 05 - 12
16
2021 - 04 - 15
17
2021 - 04 - 12
16
2021 - 03 - 18
20
2021 - 03 - 15
16
2021 - 01 - 11
15
2020 - 12 - 10
17
2020 - 12 - 09
20
2020 - 12 - 03
25
2020 - 12 - 01
27
Crawled Time
00:00
158
00:12
4
00:20
53
01:00
96
02:00
37
03:00
28
03:10
4
04:00
25
04:20
25
05:00
32
06:00
55
07:00
80
08:00
47
08:20
9
09:00
59
09:33
4
10:00
82
10:08
8
11:00
384
11:03
4
12:00
819
12:01
16
12:03
25
12:15
125
12:20
183
12:30
105
13:00
661
13:01
18
13:03
15
13:05
7
13:07
5
13:15
100
13:20
157
13:30
125
13:35
6
14:00
540
14:01
10
14:03
6
14:15
49
14:20
81
14:30
61
15:00
321
15:15
34
15:20
30
15:30
55
16:00
176
16:01
5
16:20
57
17:00
190
18:00
149
19:00
141
20:00
210
20:20
61
21:00
244
22:00
264
22:01
8
22:08
6
22:10
5
22:16
8
23:00
174
Source
alteritytherapeutics.com
16
alzamend.com
3
contravir.com
5
firstcobalt.com
4
investor.assemblybio.com
3
investors.biomarin.com
2
ir.akerotx.com
2
ir.anaptysbio.com
2
ir.arberobotics.com
2
ir.auriniapharma.com
2
ir.benitec.com
2
ir.biolinerx.com
6
ir.hoththerapeutics.com
5
ir.kalvista.com
3
ir.opgen.com
2
ir.radiuspharm.com
3
ir.vaccinex.com
2
ir.viveve.com
6
ir.zynerba.com
2
jaguarhealth.gcs-web.com
5
mindmed.co
6
neurosense.investorroom.com
3
ocutx.gcs-web.com
3
renovorx.com
2
spacfeed.com
10
velodynelidar.com
9
www.4dpharmaplc.com
6
www.achievelifesciences.com
5
www.adnas.com
5
www.agtc.com
5
www.akerotx.com
3
www.allogene.com
2
www.anaptysbio.com
3
www.anavex.com
4
www.aquestive.com
3
www.athira.com
3
www.atyrpharma.com
3
www.balchem.com
2
www.biolase.com
2
www.biospace.com
2761
www.brainsway.com
3
www.celyad.com
3
www.chi-med.com
2
www.cortexyme.com
3
www.fatetherapeutics.com
6
www.fda.gov
7
www.fsdpharma.com
5
www.globenewswire.com
2040
www.igcinc.us
6
www.inovio.com
8
www.inventivapharma.com
5
www.jupiterwellnessinc.com
7
www.nantkwest.com
10
www.novocure.com
5
www.ppdi.com
4
www.prnewswire.com
1528
www.stagindustrial.com
21
www.veeva.com
3
www.vynetherapeutics.com
4
www.zynerba.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Trial
save search
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Published:
2023-12-03
(Crawled : 00:00)
- prnewswire.com
AHCO
|
$8.83
4.13%
-0.11%
790K
|
Finance
|
Email alert
Add to watchlist
OTLK
|
$0.4728
-1.5%
-1.84%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SLRN
|
News
|
$6.88
2.38%
-2.04%
990K
|
|
Email alert
Add to watchlist
deadline
trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMR
Published:
2023-12-03
(Crawled : 20:20)
- prnewswire.com
GDHG
|
News
|
$20.55
-4.77%
1.22%
340K
|
|
Email alert
Add to watchlist
PAYC
|
News
|
$185.75
2.25%
-0.03%
1.3M
|
Technology Services
|
Email alert
Add to watchlist
corporation
deadline
trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ACELYRIN, INC. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SLRN
Published:
2023-12-03
(Crawled : 20:20)
- prnewswire.com
SLRN
|
News
|
$6.88
2.38%
-2.04%
990K
|
|
Email alert
Add to watchlist
FTCH
|
News
|
$1.28
9.4%
0.78%
32M
|
Technology Services
|
Email alert
Add to watchlist
deadline
trial
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published:
2023-12-01
(Crawled : 18:00)
- globenewswire.com
CMND
|
$4.14
18.29%
2.63%
11M
|
n/a
|
21.29%
|
O:
21.29%
H:
0.0%
C:
0.0%
SPRC
|
$7.96
1.92%
0.5%
530K
|
Manufacturing
|
-0.75%
|
O:
-0.75%
H:
0.0%
C:
0.0%
obesity
drug
pre-clinical
positive
trial
results
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published:
2023-12-01
(Crawled : 17:00)
- globenewswire.com
CMND
|
$4.14
18.29%
2.63%
11M
|
n/a
|
21.29%
|
O:
21.29%
H:
0.0%
C:
0.0%
obesity
drug
pre-clinical
positive
trial
results
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE)
Published:
2023-12-01
(Crawled : 15:00)
- biospace.com/
TOT
|
$48.3
0%
|
Energy Minerals
|
Email alert
Add to watchlist
nrtx-1001
cell
ongoing
trial
therapeutics
therapy
BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023
Published:
2023-11-30
(Crawled : 00:00)
- biospace.com/
PHGE
|
$0.258
-0.39%
0.0%
370K
|
Health Technology
|
-30.15%
|
O:
-19.28%
H:
0.0%
C:
0.0%
bx004
review
positive
fibrosis
infections
trial
results
Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
Published:
2023-11-30
(Crawled : 00:00)
- biospace.com/
ALT
|
$3.57
12.98%
3.36%
100M
|
Commercial Services
|
83.71%
|
O:
4.47%
H:
0.0%
C:
0.0%
obesity
momentum
positive
topline
trial
results
A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
CDXC
|
$1.41
1.44%
-0.71%
110K
|
Process Industries
|
4.51%
|
O:
4.51%
H:
2.16%
C:
0.0%
niagen
trial
milestone
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
NLTX
|
$3.5
1.16%
0.0%
35K
|
Health Technology
|
Email alert
Add to watchlist
ngn-401
treatment
trial
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
BNTC
|
$3.22
1.26%
1.86%
11K
|
Health Technology
|
0.0%
|
O:
0.63%
H:
8.29%
C:
-0.63%
bb-301
candidate
treatment
biopharma
trial
therapy
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
SNGX
|
$0.73
75.73%
-5.49%
7M
|
Health Technology
|
32.76%
|
O:
32.76%
H:
0.0%
C:
0.0%
fda
disease
treatment
clearance
trial
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
TARA
|
$1.435
-1.03%
-1.05%
20K
|
Health Technology
|
-2.68%
|
O:
-2.01%
H:
4.71%
C:
-0.68%
tara-002
presentation
meeting
trial
therapeutics
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-11-29
(Crawled : 14:30)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
lung
abbvie
positive
cancer
cell
topline
trial
results
SELLAS Life Sciences Reaches Target Enrollment ex-China in Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia
Published:
2023-11-29
(Crawled : 14:00)
- globenewswire.com
SLS
|
$1.08
3.85%
0.83%
480K
|
Health Technology
|
-2.8%
|
O:
-1.87%
H:
24.76%
C:
0.0%
life
sciences
leukemia
trial
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Published:
2023-11-29
(Crawled : 13:30)
- globenewswire.com
DYAI
|
$1.77
4.73%
0.0%
48K
|
Health Technology
|
-4.25%
|
O:
-0.85%
H:
5.71%
C:
-2.29%
candidate
vaccine
trial
results
Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients
Published:
2023-11-29
(Crawled : 13:00)
- globenewswire.com
TSHA
|
$1.84
4.55%
-2.72%
1.6M
|
Health Technology
|
0.57%
|
O:
3.43%
H:
3.87%
C:
0.55%
reveal
trial
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease
Published:
2023-11-29
(Crawled : 13:00)
- globenewswire.com
BIVI
P
|
$1.68
-6.67%
4.17%
1.3M
|
Health Technology
|
-66.91%
|
O:
-70.4%
H:
0.0%
C:
0.0%
ne3107
disease
alzheimer’s
trial
Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification
Published:
2023-11-29
(Crawled : 13:00)
- globenewswire.com
PBLA
|
$0.5987
12.96%
-11.69%
350K
|
Professional, Scientific, and T...
|
21.33%
|
O:
21.33%
H:
0.0%
C:
0.0%
continuation
review
aspire
trial
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes
Published:
2023-11-29
(Crawled : 12:30)
- globenewswire.com
SABS
|
$0.94
-3.29%
4.26%
250K
|
|
8.47%
|
O:
0.44%
H:
2.22%
C:
-3.33%
sab-142
trial
diabetes
potential
← Previous
1
2
3
4
5
6
7
8
9
…
334
335
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.